Intrathecal trastuzumab versus alternate routes of delivery for HER2-targeted therapies in patients with HER2+ breast cancer leptomeningeal metastasesAnna-Maria Lazaratos, Matthew Dankner, Amélie Darlix et al.|The Breast|2023Cited by 25